Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

10 T. Rowe Price ETFs Cross $1 Billion in AUM

BY | ETF Database
7:33 am ET 05/18/26 | 15 VIEWS
In a notable milestone, T. Rowe Price now holds ten ETFs with $1 billion in AUM. This comes following the T. Rowe Price Growth ETF (TGRW B-) being the latest to cross that threshold. The firm’s ten $1 billion plus funds cover a variety of ETF categories, and together speak to the growing, significant appeal of active investing and the ETF wrapper.Key Takeaways: Active ETFs have picked up major inflows relative to their overall AUMs, shining bright in the overall ETF ecosystem. The ETF rule in 2019 helped streamline ETF launches with T. Rowe Price emerging as a leader in active ETF innovation. Today, the firm sports ten active ETFs that can claim at least $1 billion in AUM, a milestone for its active suite. The ETF landscape has seen massive growth in recent years with active ETFs being particularly popular. Since the ETF Rule in 2019 has helped to streamline the launch process, asset managers have leveled up the playing field with increasing innovation and T. Rowe Price is no exception.  The firm’s largest active ETF is the T. Rowe Price Capital Appreciation Equity ETF (TCAF B+). Launched in 2023, the fund is approaching its three-year milestone next month and has already crossed the $7 billion AUM mark. Managed by David Giroux, TCAF targets higher quality U.S. large caps with above average growth potential. In addition to TGRW and TCAF, the firm has six other equity ETFs above $1 billion in AUM and two bond funds in that echelon as well. The T. Rowe Price Small-Mid Cap ETF (TMSL B+) has added the largest flows YTD, according to ETF Database data, with more than $800 million in that time. TMSL has also led performance in the AUM top ten category, returning 13.96% YTD. See more: Leading Active ETF TCAF Crosses $7 Billion AUM Milestone The firm’s largest bond ETFs, the T. Rowe Price QM U.S. Bond ETF (TAGG ) and the T. Rowe Price Ultra Short-Term Bond ETF (TBUX ) come in at $1.9 billion and $1.1 billion, respectively. Those strategies have both added more than a quarter billion YTD in net inflows. With ten active ETFs now crossing the $1 billion mark, T. Rowe Price offers a robust “full house” of investment options. These funds utilize the firm’s signature fundamental research to help investors and advisors build more resilient, outperforming portfolios in an uncertain 2026. For more news, information, and analysis, visit our Active ETF Content Hub.

More Commentary

With Robinhood Growth Still Solid, Monitor This ETF
BY | ETF Database
9:51 am ET 05/18/26 | 28 VIEWS
3 Ways to Play the S&P 500 Based on Your Risk Tolerance
BY | ETF Database
5:14 am ET 05/18/26 | 71 VIEWS
Tuned For Performance: Why SNPE is Winning the S&P Race
BY | ETF Database
10:40 am ET 05/18/26 | 24 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.